Skip to content
Visnia
CtrlK
EconomyAI buildoutMarket MapFundsWatchlist
Log in
Market cap
Revenue
Net income
Cash on hand
Gross margin
Net margin
EPS
P/E ratio
Search
Market mapFundsWatchlist
Visnia

XXORTX Therapeutics Inc.

EconomyAI buildoutMarket MapFundsWatchlist
Log in
X

XORTX Therapeutics Inc.

  • Overview
  • Financial statements
  • Metrics
  • Quarterly earnings
  • Similar companies
  • News
  • Insider Transactions

News

News

  • XORTX Announces Planned FDA IND Submission for XRx-026 Gout Program Using XORLO™, Targeting USD$700M+ U.S. Gout Market Opportunity
    Sep 18, 2026XORTX Therapeutics Inc. (XRTX) Press Releases
  • XORTX Announces Initiation of Clinical and Commercial Manufacturing of XORLO™
    Sep 10, 2026XORTX Therapeutics Inc. (XRTX) Press Releases
  • XORTX Re-Engages Investor Relations Program
    Sep 8, 2026XORTX Therapeutics Inc. (XRTX) Press Releases
  • XORTX Announces Termination and Postponement of Investor Relations Program
    Aug 28, 2026XORTX Therapeutics Inc. (XRTX) Press Releases
  • XORTX Announces Director Resignation
    Jul 31, 2026XORTX Therapeutics Inc. (XRTX) Press Releases
  • XORTX Appoints New Director
    Jul 29, 2026XORTX Therapeutics Inc. (XRTX) Press Releases
  • XORTX Provides Corporate Update and Announces Appointment of Mika Grasso as Co-CEO
    Jun 15, 2026XORTX Therapeutics Inc. (XRTX) Press Releases
  • XORTX Announces Election to Voluntary Delist from the TSX Venture Exchange
    Jun 12, 2026XORTX Therapeutics Inc. (XRTX) Press Releases
  • XORTX Announces Closing of US$5 Million Public Offering
    May 19, 2026XORTX Therapeutics Inc. (XRTX) Press Releases
  • XORTX Announces US$5 Million Public Offering
    May 14, 2026XORTX Therapeutics Inc. (XRTX) Press Releases
  • Overview
  • Financial statements
  • Metrics
  • Quarterly earnings
  • Burn Rate
  • Similar companies
  • News
  • Insider Transactions